IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0578436
(2009-10-13)
|
등록번호 |
US-8524286
(2013-09-03)
|
발명자
/ 주소 |
|
출원인 / 주소 |
- Nerium Biotechnology, Inc.
|
대리인 / 주소 |
Knobbe Martens Olson & Bear LLP
|
인용정보 |
피인용 횟수 :
4 인용 특허 :
9 |
초록
▼
The present invention pertains to methods of extracting cardiac glycosides from cardiac glycoside containing plant material, such as Nerium oleander, through use of aloe. It further provides for compositions resulting from such extractions, pharmaceutical compositions, cosmetic compositions, and met
The present invention pertains to methods of extracting cardiac glycosides from cardiac glycoside containing plant material, such as Nerium oleander, through use of aloe. It further provides for compositions resulting from such extractions, pharmaceutical compositions, cosmetic compositions, and methods of treating skin conditions.
대표청구항
▼
1. A cardiac glycoside aloe composition comprising a Nerium oleander aloe extract, wherein said extract is prepared by extracting Nerium oleander with aloe to create an extraction mixture comprising liquid and solid material and separating the solid material from the liquid material; wherein said li
1. A cardiac glycoside aloe composition comprising a Nerium oleander aloe extract, wherein said extract is prepared by extracting Nerium oleander with aloe to create an extraction mixture comprising liquid and solid material and separating the solid material from the liquid material; wherein said liquid material is the Nerium oleander aloe extract. 2. A pharmaceutical composition comprising the cardiac glycoside aloe composition of claim 1, and further comprising a pharmaceutically acceptable carrier. 3. The pharmaceutical composition of claim 2 in pill, sublingual or cosmetic form. 4. The pharmaceutical composition of claim 2 wherein the pharmaceutically acceptable carrier comprises a dermal agent. 5. A method of treating a skin condition, comprising administering an effective amount of the composition of claim 4 to a subject in need thereof; wherein said skin condition is selected from the group consisting of abscesses, dry skin, sun-damaged skin, aging skin, acne, actinic keratosis, age spots, liver spots, burns, sunburn, heat burn, radiation burn, cold sores, corns, eczema, psoriasis, ringworm, scabies, skin tags, warts and combinations thereof. 6. A method of applying a cosmetic, comprising applying the cardiac glycoside aloe composition of claim 1 to the skin of a subject. 7. A method of applying a cosmetic, comprising: identifying a subject in need of cosmetic application; andapplying a cosmetically effective amount of the cardiac glycoside aloe composition of claim 1 or claim 4 to the skin of said subject, whereinsaid subject has a skin condition selected from the group consisting of abscesses, dry skin, sun-damaged skin, aging skin, acne, actinic keratosis, age spots, liver spots, burns, sunburn, heat burn, radiation burn, cold sores, corns, eczema, psoriasis, ringworm, scabies, skin tags, warts and combinations thereof. 8. A method of extracting cardiac glycosides, comprising: mixing Nerium oleander having cardiac glycosides with aloe to form an extraction mixture andseparating the extract from the solid Nerium oleander plant material. 9. The method of claim 8, wherein the method further comprises heating said extraction mixture for about 1 to about 10 hours. 10. The method of claim 8, wherein the method further comprises heating said extraction mixture to a temperature in the range of about 40° C. to about 100° C. 11. The method of claim 8 wherein said separating comprises filtering, centrifuging or decanting. 12. The method of claim 8, wherein the extraction mixture comprises Nerium oleander in a range of about one part to about 50 parts by weight and wherein the extraction mixture comprises aloe in a range of about one part to about 100 parts by weight. 13. The method of claim 8, wherein the extraction mixture comprises a solvent selected from the group consisting of alcohols, ketones, ethers, esters and mixtures thereof. 14. The method of claim 13, wherein said solvent is selected from the group consisting of methanol, ethanol, n-propanol, iso-propanol, methoxyethanol, 2-butoxyethanol, diethyl ether, acetone, butanone, ethyl acetate, and mixtures thereof. 15. A cardiac glycoside aloe composition comprising a cardiac glycoside aloe extract, wherein said cardiac glycoside aloe extract is prepared by extracting a plant with aloe to create an extraction mixture comprising liquid and solid material and separating the solid material from the liquid material, wherein said liquid material is the cardiac glycoside aloe extract and wherein said plant consists of a cardiac glycoside plant selected from Digitalis purpurea, Digitalis lanate, Convallaria majalis, Urginea maritime, Urginea indica, Strophanthus gratus, Apocynum cannabinum, Cheiranthus cheiri and Nerium indicum. 16. A pharmaceutical composition comprising the cardiac glycoside aloe composition of claim 15 and further comprising a pharmaceutically acceptable carrier. 17. The pharmaceutical composition of claim 16 in pill, sublingual or cosmetic form. 18. The pharmaceutical composition of claim 16 wherein the pharmaceutically acceptable carrier comprises a dermal agent. 19. A method of treating a skin condition, comprising administering an effective amount of the composition of claim 15 or claim 18 to a subject in need thereof; wherein said skin condition is selected from the group consisting of abscesses, dry skin, sun-damaged skin, aging skin, acne, actinic keratosis, age spots, liver spots, burns, sunburn, heat burn, radiation burn, cold sores, corns, eczema, psoriasis, ringworm, scabies, skin tags, warts and combinations thereof. 20. A method of applying a cosmetic, comprising applying the cardiac glycoside composition of claim 15 or claim 18 to the skin of a subject. 21. A method of applying a cosmetic, comprising: identifying a subject in need of cosmetic application; andapplying a cosmetically effective amount of the cardiac glycoside composition of claim 15 or claim 18 to the skin of said subject, whereinsaid subject has a skin condition selected from the group consisting of abscesses, dry skin, sun-damaged skin, aging skin, acne, actinic keratosis, age spots, liver spots, burns, sunburn, heat burn, radiation burn, cold sores, corns, eczema, psoriasis, ringworm, scabies, skin tags, warts and combinations thereof. 22. A method of extracting cardiac glycosides, comprising: mixing a composition consisting of a cardiac glycoside plant and aloe to form an extraction mixture, separating the liquid extract from the solid cardiac glycoside plant material and collecting the liquid extract; wherein the cardiac glycoside plant is selected from Digitalis purpurea, Digitalis lanate, Convallaria majalis, Urginea maritime, Urginea indica, Strophanthus gratus, Apocynum cannabinum, Cheiranthus cheiri and Nerium indicum. 23. The method of claim 22, wherein the method further comprises heating said extraction mixture for about 1 to about 10 hours. 24. The method of claim 22, wherein the method further comprises heating said extraction mixture to a temperature in the range of about 40° C. to about 100° C. 25. The method of claim 22 wherein said separating comprises filtering, centrifuging or decanting. 26. The method of claim 22, wherein the extraction mixture comprises the cardiac glycoside plant in a range of about one part to about 50 parts by weight and wherein the extraction mixture comprises aloe in a range of about one part to about 100 parts by weight. 27. The method of claim 22, wherein the extraction mixture comprises a solvent selected from the group consisting of alcohols, ketones, ethers, esters and mixtures thereof. 28. The method of claim 27, wherein said solvent is selected from the group consisting of methanol, ethanol, n-propanol, iso-propanol, methoxyethanol, 2-butoxyethanol, diethyl ether, acetone, butanone, ethyl acetate and mixtures thereof. 29. The cardiac glycoside aloe composition of claim 1 further comprising polysaccharides. 30. The cardiac glycoside aloe composition of claim 15 further comprising polysaccharides.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.